IFM Investors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.82M | Hold |
|
|||||
|
2025
Q2 | $2.49M | Buy |
|
|||||
|
2025
Q1 | $2.03M | Sell |
|
|||||
|
2024
Q4 | $2.59M | Sell |
|
|||||
|
2024
Q3 | $2.24M | Hold |
|
|||||
|
2024
Q2 | $2.68M | Buy |
|
|||||
|
2024
Q1 | $2.58M | Buy |
|
|||||
|
2023
Q4 | $2.4M | Hold |
|
|||||
|
2023
Q3 | $2.05M | Buy |
|
|||||
|
2023
Q2 | $1.67M | Sell |
|
|||||
|
2023
Q1 | $1.8M | Buy |
|
|||||
|
2022
Q4 | $1.95M | Sell |
|
|||||
|
2022
Q3 | $1.87M | Sell |
|
|||||
|
2022
Q2 | $1.74M | Sell |
|
|||||
|
2022
Q1 | $1.7M | Buy |
|
|||||
|
2021
Q4 | $1.33M | Buy |
|
|||||
|
2021
Q3 | $1.41M | Buy |
|
|||||
|
2021
Q2 | $1.36M | Buy |
|
|||||
|
2021
Q1 | $982K | Buy |
|
|||||
|
2020
Q4 | $844K | Buy |
|
|||||
|
2020
Q3 | $695K | Buy |
|
|||||
|
2020
Q2 | $795K | Sell |
|
|||||
|
2020
Q1 | $680K | Sell |
|
|||||
|
2019
Q4 | $801K | Buy |
|